21 CFR 801.50
§ 801.50 Labeling requirements for stand-alone software.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 801.50, § 801.50 Labeling requirements for stand-alone software, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88666
- Permanent ID
ys:prov:88666@1- SHA-256
ad39a0c49b9b9870b25e7c7f9e832ad1c6949f733cd0d659f3ba28b96e2d9e41
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Stand-alone software that is not distributed in packaged form (e.g., when downloaded from a Web site) is deemed to meet the UDI labeling requirements of this subpart if it complies with the requirements of paragraph (b) of this section and conveys the version number in its production identifier.
(b) Regardless of whether it is or is not distributed in packaged form, stand-alone software regulated as a medical device must provide its unique device identifier through either or both of the following:
(1) An easily readable plain-text statement displayed whenever the software is started;
(2) An easily readable plain-text statement displayed through a menu command (e.g., an “About * * *” command).
(c) Stand-alone software that is distributed in both packaged form and in a form that is not packaged (e.g., when downloaded from a Web site) may be identified with the same device identifier.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.